{
    "code": "01036434",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036434",
    "time": "2018-08-31 04:32:54",
    "許可證字號": "衛署藥製字第036434號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/06\/09",
    "發證日期": "82\/06\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103643405",
    "中文品名": "“安成”啡莫替定凍晶注射劑２０毫克",
    "英文品名": "FAMOTIDIN LYO-INJECTION 20MG “TWi”",
    "適應症": "住院病人伴隨有病理性胃酸分泌過高之症狀、頑固性（難治的）十二指腸潰瘍、或不能口服之病人消化性潰瘍之短期替代療法。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "FAMOTIDINE"
    ],
    "限制項目": "01國　產 1G依藥品審查準則第64條 不得製造",
    "申請商名稱": "6201117648  安成國際藥業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640002100",
            "成分名稱": "FAMOTIDINE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010364340001-103-01-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036434&Seq=001&Type=9"
        }
    ]
}